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Abstract
Following traumatic brain injury (TBI), treatment with rapamycin suppresses mammalian (mechanistic) target
of rapamycin (mTOR) activity and specific components of hippocampal synaptic reorganization associated
with altered cortical excitability and seizure susceptibility. Reemergence of seizures after cessation of
rapamycin treatment suggests, however, an incomplete suppression of epileptogenesis. Hilar inhibitory
interneurons regulate dentate granule cell (DGC) activity, and de novo synaptic input from both DGCs and
CA3 pyramidal cells after TBI increases their excitability but effects of rapamycin treatment on the injury-
induced plasticity of interneurons is only partially described. Using transgenic mice in which enhanced green
fluorescent protein (eGFP) is expressed in the somatostatinergic subset of hilar inhibitory interneurons, we
tested the effect of daily systemic rapamycin treatment (3 mg/kg) on the excitability of hilar inhibitory
interneurons after controlled cortical impact (CCI)-induced focal brain injury. Rapamycin treatment reduced,
but did not normalize, the injury-induced increase in excitability of surviving eGFP hilar interneurons. The
injury-induced increase in response to selective glutamate photostimulation of DGCs was reduced to normal
levels after mTOR inhibition, but the postinjury increase in synaptic excitation arising from CA3 pyramidal cell
activity was unaffected by rapamycin treatment. The incomplete suppression of synaptic reorganization in
inhibitory circuits after brain injury could contribute to hippocampal hyperexcitability and the eventual
reemergence of the epileptogenic process upon cessation of mTOR inhibition. Further, the cell-selective
effect of mTOR inhibition on synaptic reorganization after CCI suggests possible mechanisms by which
rapamycin treatment modifies epileptogenesis in some models but not others.
Key words: dentate gyrus; epilepsy; interneuron; mossy fiber; mTOR; photostimulation
Significance Statement
Rapamycin inhibits mammalian (mechanistic) target of rapamycin (mTOR) signaling to suppress abnormal
patterns of cell growth and circuit reorganization found in pathologies such as acquired epilepsy, tuberous
sclerosis, and cancer. Here, rapamycin was studied for its effects on hippocampal circuit reorganization in
a model of focal brain injury that leads to spontaneous seizures in a subset of mice. Rapamycin treatment
in these animals reduced the injury-induced excitatory synaptic input from DGCs onto surviving hilar
interneurons, but failed to prevent the backprojection of CA3 pyramidal cells onto these interneurons seen
after brain injury. These findings indicate that mTOR inhibition fails to ubiquitously suppress recurrent
excitatory synaptic reorganization after brain injury, and suggests that rapamycin’s effects on reactive
axonal plasticity in the hippocampal formation are cell-type specific.
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Introduction
Functional reactive plasticity of dentate granule cells
(DGCs), CA3 pyramidal cells, and hilar inhibitory neurons
has been associated with epilepsy development after se-
vere traumatic brain injury (TBI; Scharfman, 2007; Hunt
et al., 2009; Halabisky et al., 2010; Hunt et al., 2010, 2011;
Pavlov et al., 2011; Gupta et al., 2012; Guo et al., 2013).
Although the nature of their contribution is controversial,
the sprouting of DGC axons (i.e., mossy fiber sprouting;
MFS) may contribute to the formation of an epileptogenic
circuit. Increased excitability of somatostatinergic hilar
inhibitory interneurons is also a component of this synap-
tic reorganization (Halabisky et al., 2010; Hunt et al.,
2011). These interneurons function to inhibit DGC activity
after perforant pathway activation, and are particularly
susceptible to cell death after TBI (Lowenstein et al.,
1992; Hicks et al., 1993; Butler et al., 2016). After an
epileptogenic insult, increased synaptic input arising de
novo from both DGCs and CA3 pyramidal neurons drives
the increased excitability of surviving hilar interneurons
(Halabisky et al., 2010; Hunt et al., 2011). The reorgani-
zation of excitatory synaptic input to hilar inhibitory in-
terneurons is therefore a component of the altered
excitation-inhibition balance in the hippocampus associ-
ated with epileptogenesis after TBI, and hyperexcitability
of inhibitory neurons may promote epileptiform activity
(Yekhlef et al., 2015; Shiri et al., 2017).
Treatment with the mammalian (mechanistic) target of
rapamycin (mTOR) inhibitor, rapamycin in the controlled
cortical impact (CCI) model of posttraumatic epilepsy
(PTE) reduces spontaneous seizure development (Guo
et al., 2013; Butler et al., 2015). Rapamycin also sup-
presses several cellular correlates of epileptogenesis, in-
cluding axon remodeling in the dentate gyrus after CCI
and in the pilocarpine-induced status epilepticus (SE)
model of temporal lobe epilepsy (TLE; Buckmaster et al.,
2009; Buckmaster and Lew, 2011; Buckmaster and Wen,
2011; Guo et al., 2013; Butler et al., 2015; Yamawaki et al.,
2015), but other effects of mTOR inhibition on TBI-
induced cortical synaptic plasticity are not well under-
stood. Accordingly, cessation of treatment results in the
reemergence of seizures and synaptic reorganization
(Buckmaster et al., 2009; Guo et al., 2013), and epilepto-
genesis is not prevented in some models (Heng et al.,
2013), suggesting rapamycin treatment may alleviate only
a subset of the functional cellular changes underlying
epileptogenesis. For example GABAA receptors undergo
functional changes after CCI that persist for months after
the injury (Boychuk et al., 2016) and these changes are
not universally constrained by rapamycin treatment (But-
ler et al., 2016). Additionally, the de novo emergence of
convergent synaptic inputs onto surviving inhibitory neu-
rons after TBI could powerfully affect hippocampal func-
tion (Hunt et al., 2011), but mTOR’s involvement in this
synaptic remodeling is unknown. Here, we used trans-
genic mice in which somatostatinergic hilar inhibitory in-
terneurons express enhanced green fluorescent protein
(eGFP) (Oliva et al., 2000) to study effects of mTOR inhi-
bition on reorganization of excitatory synaptic input to
hilar inhibitory interneurons after CCI injury. We tested the
hypothesis that continual rapamycin treatment after CCI
obviates injury-induced formation of new excitatory syn-
aptic connections arising from both DGCs and CA3 py-
ramidal cells onto surviving hilar inhibitory interneurons.
Materials and Methods
Animals
Male FVB-Tg(GadGFP)4570Swn/J mice (i.e., GIN mice;
The Jackson Laboratory) age six to eight weeks old,
weighing 23–28 g, or male CD-1 mice (Harlan) age six to
eight weeks old, weighing 30–35 g, were housed in a
normal 14/10 h light/dark cycle. Mice were housed in the
University of Kentucky vivarium for a minimum of 7 d
before experimentation; food and water was provided ad
libitum. GIN mice express eGFP in the somatostatinergic
subset of GABAergic interneurons in cortical brain re-
gions; in the hilus, somatostatin is expressed in 95% of
eGFP-labeled (eGFP) hilar interneurons (Oliva et al.,
2000). All procedures were approved by the University of
Kentucky Animal Care and Use Committee and followed
the National Institutes of Health guidelines for the care
and treatment of animals.
TBI
Mice were subjected to severe unilateral, cortical con-
tusion injury by CCI, as described previously (Dixon et al.,
1991; Scheff et al., 1997; Hall et al., 2005; Hunt et al.,
2009; Guo et al., 2013; Butler et al., 2015). Briefly, mice
were anesthetized by 2% isoflurane inhalation and placed
in a stereotaxic frame. The skull was exposed by midline
incision, and 5 mm craniotomy was made lateral to the
sagittal suture, centered between bregma and lambda.
The skull cap was carefully removed, avoiding damage to
the exposed underlying dura. The contusion device con-
sisted of a computer-controlled, pneumatically driven im-
pactor fitted with a beveled stainless-steel tip 3 mm in
diameter (TBI-0310, Precision Systems and Instrumenta-
tion). A focal, nonpenetrating brain injury was delivered to
compress the cortex 1.0 mm in depth (hard stop) at a
velocity of 3.5 m/s and 500 ms duration. A qualitative
postoperative health assessment was performed daily for
4 d after CCI and periodically thereafter.
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Rapamycin treatment
Rapamycin (LC Labs) was initially dissolved in 100%
ethanol (20 mg/ml), stored at 20°C, and diluted in a
vehicle solution containing 5% Tween 80, 5% PEG 400,
and 4% ethanol in distilled, deionized water immediately
before injection (Guo et al., 2013; Heng et al., 2013; Butler
et al., 2015). Rapamycin (3 mg/kg; i.p.) or vehicle was
injected after mice regained consciousness following CCI
injury (20–30 min) and continued once daily until the
mouse was used for experimentation. All other chemicals
were obtained from Fischer Scientific unless otherwise
indicated.
Slice preparation
Mice were deeply anesthetized by isoflurane inhalation
to effect (lack of tail pinch response) and decapitated
while anesthetized. The brain was removed and placed in
ice-cold (2–4°C) artificial CSF (ACSF) containing 124 mM
NaCl, 3 mM KCl, 2 mM CaCl2, 26 mM NaHCO3, 1.3 mM
MgCl2, 11 mM glucose, and 1.4 mM NaH2PO4 equili-
brated with 95% O2-5% CO2 (pH 7.2–7.4). Brains were
blocked, glued to a sectioning stage, and 350-m-thick
coronal slices were cut in cold, oxygenated ACSF using a
vibrating microtome (Vibratome Series 1000; Technical
Products International). The hippocampus was isolated
from surrounding tissue, making sure to completely re-
move the entorhinal cortex, thereby avoiding synaptic
excitation of hilar inhibitory interneurons by activity of
intact cortical neurons mediating performant path input. In
a subset of slices, a scalpel cut was made across the hilus
to isolate the dentate gyrus from the CA3 pyramidal cell
layer to abrogate action potential-dependent excitatory
neurotransmission in GFP hilar interneurons that arose
from CA3. Slices were transferred to a storage chamber
containing oxygenated warmed ACSF (32–34°C). Slices
of the septal and temporal hippocampus from the hemi-
spheres ipsilateral and contralateral to CCI injury were
used in these experiments and compared to comparable
slices from sham-injured mice (i.e., craniotomy, but no
impact injury).
Whole-cell patch-clamp and on-cell recordings
After an equilibration period of at least 1 h, a single slice
was transferred to a recording chamber on an upright,
fixed-stage microscope equipped with epifluorescence
and infrared, differential interference contrast optics (IR-
DIC; Olympus BX50WI), where it was continuously super-
fused with warmed (32–34°C) oxygenated ACSF.
Recordings were performed from eGFP-labeled (i.e.,
eGFP) hilar interneurons, identified by epiflorescence
illumination, and DGCs or CA3 pyramidal cells identified
using DIC imaging. Recording pipettes were made from
borosilicate glass (1.65 mm outer diameter, 0.45 mm inner
diameter; King Precision Glass) with a P-87 horizontal
puller (Sutter Instrument). The intracellular solution con-
tained 130 mM K-gluconate, 1 mM NaCl, 5 mM EGTA,
10 mM HEPES, 1 mM MgCl2, 1 mM CaCl2, 3 mM KOH,
and 2 mM ATP. Open tip resistance was 2–5 M. Record-
ings were obtained using an Axon Axopatch 200B or Axon
Multiclamp 700B amplifier (Molecular Devices), low-pass
filtered at 2–5 kHz, digitized at 20 kHz with a Digidata
1322A or Digidata 1550A (Molecular Devices), and ac-
quired using pClamp 10.2 or 10.5 programs (Clampfit,
Molecular Devices). On-cell recordings of spontaneous
sodium currents mediating action potential firing were
made with no holding command. In a subset of record-
ings, the ionotropic glutamate receptor antagonist, kyn-
urenic acid (30 M) was added to the ACSF. Whole-cell
patch-clamp recordings of spontaneous and evoked
EPSCs (sEPSCs and eEPSCs) were made in voltage-
clamp mode at 70mV. EPSCs were identified as tran-
sient inward currents having a rapid rise and single
exponential decay. EPSCs were analyzed using Mini-
Analysis software (version 6.0.3, Synaptosoft; Decatur
GA) and only included events with amplitudes 3 RMS.
Glutamate photostimulation
Slices were superfused with 4-methoxy-7-nitroin-
dolinyl-caged-L-glutamate (i.e., MNI-caged glutamate;
250 M; Tocris) added to recirculating, oxygenated ACSF.
Brief pulses of fluorescent light (30 ms; UV filter; Chroma
Technology) were directed into the slice through the 40
microscope objective with aperture and filter at lowest
levels (Bhaskaran and Smith, 2010; Hunt et al., 2010,
2011). The objective was initially positioned to uncage
glutamate directly over the recorded neuron, which con-
sistently resulted in a large inward current and action
potentials. The effective radius of stimulation (60 m)
was determined by manually moving the focal point of the
stimulus in three different directions away from the re-
corded neuron until a direct inward current after stimula-
tion was no longer observed. The objective was then
moved to the dentate gyrus or CA3 pyramidal cell layer
and photostimulation was applied focally to stereotyped
sites along the DGC layer (tips of upper and lower blades,
apex, and a midpoint on each blade between tip and
apex) and in the proximal CA3 region. Five stimuli were
applied per stimulation site at 0.1 Hz (five sweeps). For
analysis, eEPSCs were assessed by comparing EPSC
frequency during the period 1 s before (normalized to a
200-ms period) and 200 ms after the uncaging event
(eEPSC frequency per sweep  #EPSCs after stim -
#EPSCs prestim; final values were calculated as the mean
difference over the five sweeps). Threshold for a positive
responding site was set at a mean net increase of one
eEPSC over five sweeps, as previously described (Hunt
et al., 2011). Each eGFP neuron then received a per-
centage score for the number of effective stimulation sites
after DGC and CA3 photostimulation (i.e., percentage
stimulation sites resulting in a synaptic response).
We tested the possibility that variability in background
sEPSC frequency could account for apparent synaptic
responses; we analyzed seven to eight randomly selected
1200-ms segments of sEPSC recordings from eGFP
neurons (i.e., in the absence of glutamate uncaging; n 
4–6 cells from each experimental group). Five sequential
segments of recording were analyzed and averaged to
mirror the five sweeps used in the analysis above. In each
recording segment, the frequency of sEPSCs was mea-
sured during 1 s (normalized to a 200-ms bin) and then
again in the subsequent 200 ms. sEPSC frequency in the
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subsequent 200 ms was then subtracted from the sEPSC
frequency in the earlier normalized 200-ms bin to calcu-
late a change in sEPSC frequency (i.e., 	sEPSC fre-
quency), analogous to how eEPSC frequency was
calculated above (except no stimulus was applied). The
mean 	sEPSC frequency across all the experimental
groups was 0.005 
 0.032; only three of 192 (1.6%)
	sEPSC frequencies were 1. The experimental groups
did not statistically differ from one another in 	sEPSC
frequency values (Kruskal Wallis stat  5.437, p 
0.3650 a). These results indicate that eEPSC frequen-
cies 1 are unlikely to be due to changes in back-
ground sEPSCs and supports the use of this threshold
for defining positive stimulation sites.
Statistical analysis
All data were assessed for normality using Shapiro-Wilk
test and inspection of descriptive statistics to determine
use of parametric or nonparametric statistical tests. Sta-
tistical analysis was performed using GraphPad Prism
software (GraphPad Software), and a priori power analy-
ses were used to determine sample sizes based on effect
sizes from preliminary experiments. Parametric data were
assessed using one-way ANOVA with Tukey’s post hoc
comparisons. Nonparametric data were assessed using
Kruskal-Wallis statistic with Dunn’s post hoc compari-
sons. Data are expressed as mean 
 SEM, except that
glutamate photostimulation data are expressed as the
percentage of responding sites per neuron. Significance
was set at p  0.05. Table 1 indicates the tests used for
each assessment and includes the retrospective power
calculation for each statistical measurement.
Results
Weight gain following CCI injury
A recent study in a mouse model of pilocarpine-induced
SE described pathologic weight gain after SE that was re-
versed by rapamycin treatment (Hester et al., 2016). Addi-
tionally, rapamycin treatment in other murine models of
disease has resulted in reduced weight gain and increased
longevity (Deblon et al., 2012; Staats et al., 2013; Hebert
et al., 2014; Hsieh et al., 2016). To determine the effect of
CCI injury and rapamycin treatment on body weight, mice
were weighed at the time of injury and at the time of tissue
sample collection (8–12 weeks after injury) in a subset of the
mice used in this study. There was a significant difference in
weight gain between the three experimental groups (one-
way ANOVA; F(2,63)  37.40; p  0.0001
b). Weight gain in
vehicle-treated mice given sham or CCI injury was not sig-
nificantly different (sham  28.46 
 2.94%; CCI 
22.92% 
 1.95%; Tukey’s: p  0.9155), but mice given rapa-
mycin treatment after CCI injury gained less weight than either
sham or CCI injured mice (CCI  Rapa  7.61 
 0.89%;
Tukey’s: vs sham p  0.0001; vs CCI p  0.0001). Neither
pathologic weight gain following CCI injury, as reported
following pilocarpine-induced SE (Hester et al., 2016), nor
weight loss after rapamycin were observed. Instead, rapa-
mycin treatment resulted in reduced weight gain following
CCI injury, similar to previous reports (Deblon et al., 2012;
Staats et al., 2013; Hebert et al., 2014; Hsieh et al., 2016).
Spontaneous action potential and sEPSC frequency
in eGFP hilar interneurons
Weeks after pilocarpine-induced SE or CCI injury, sur-
viving eGFP hilar interneurons ipsilateral to the injury
Table 1. Statistical table
Outcome measure Data structure Type of test Power
a. 	sEPSC frequency Nominal data, non-normal
distribution
Kruskal Wallis 0.05
b. Weight change Normal distribution One-way ANOVA 0.99
c. Action potential firing rate Normal distribution One-way ANOVA 0.98
d. sEPSC frequency Normal distribution One-way ANOVA 0.8
e. sEPSC amplitude Normal distribution One-way ANOVA 0.06
f. eGFP neuron whole-cell capacitance Normal distribution One-way ANOVA 0.72
g. DGC RMP Normal distribution One-way ANOVA 0.05
h. eGFP neuron RMP Normal distribution One-way ANOVA 0.06
i. CA3 neuron RMP Normal distribution One-way ANOVA 0.11
j. Direct photostimulation evoked AP’s in DGCs Normal distribution One-way ANOVA 0.05
k. Direct photostimulation evoked AP’s in eGFP neurons Normal distribution One-way ANOVA 0.05
l. Direct photostimulation evoked AP’s in CA3 neurons Normal distribution One-way ANOVA 0.05
m. % effective stimulation sites to DG photostimulation
per eGFP neuron, controls
Nominal data, non-normal
distribution
Kruskal Wallis 0.05
n. % effective stimulation sites to DG photostimulation
per eGFP neuron
Nominal data, non-normal
distribution
Kruskal Wallis 0.68
o. % effective stimulation sites to CA3 photostimulation
per eGFP neuron, controls
Nominal data, non-normal
distribution
Kruskal Wallis 0.05
p. % effective stimulation sites to CA3 photostimulation
per eGFP neuron
Nominal data, non-normal
distribution
Kruskal Wallis 0.4
q. % effective stimulation sites to CA3 photostimulation
per DGC nACSF
Nominal data, non-normal
distribution
Kruskal Wallis 0.05
r. % responsive sites to CA3 photostimulation per DGC ACSF
w/30 M Bic
Nominal data, non-normal
distribution
Kruskal Wallis 0.12
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display increased spontaneous action potential firing and
sEPSC frequency (Halabisky et al., 2010; Hunt et al.,
2011). Rapamycin treatment suppresses MFS in the den-
tate gyrus (Buckmaster and Lew, 2011; Guo et al., 2013;
Butler et al., 2015), but the effect of mTOR inhibition on
activity and synaptic input to eGFP hilar interneurons
after CCI is not known. Spontaneous action potential
firing rate was recorded (on cell) in eGFP hilar interneu-
rons in slices from sham-injured mice (n  6 cells, 5 mice),
CCI-injured mice that were treated daily with vehicle (con-
tralateral, n  10; ipsilateral, n  12; 10 mice), and CCI-
injured mice that were treated daily for 8–12 weeks with
rapamycin (contralateral, n  8; ipsilateral, n  9; 11
mice). There was no significant difference between cells
from contralateral and ipsilateral hemispheres in sham-
injured mice for any measurements made (p  0.05);
results from sham-injured mice were therefore combined
into one group. Representative traces showing spontane-
ous action potential firing in eGFP neurons from control
(i.e., sham and contralateral hemisphere), ipsilateral to
CCI injury with vehicle treatment, and ipsilateral to CCI
injury with rapamycin treatment groups are shown in Fig-
ure 1A. We detected increased firing rates in eGFP hilar
interneurons ipsilateral to CCI injury relative to eGFP
interneurons from the contralateral hippocampus or from
sham-injured mice, as has been reported previously (Hunt
et al., 2011; sham  4.22 
 1.16 Hz; CCI contra  3.93 

0.76 Hz; CCI ipsi  11.79 
 0.94 Hz; F(4,43)  21.38; p 
0.0001c, Tukey’s: sham vs CCI ipsi p  0.0002; CCI
contra vs CCI ipsi p  0.0001; Fig. 1B). After rapamycin
treatment, action potential firing rate in eGFP interneu-
rons ipsilateral to CCI-injury was reduced relative to
CCI  vehicle mice, but remained significantly elevated
compared to eGFP interneurons from sham-injured
mice or cells contralateral to CCI injury (CCI  Rapa
contra  4.43 
 0.64 Hz, CCI  Rapa ipsi  8.86 
 0.49
Hz, Tukey’s: sham vs CCI  Rapa ipsi p  0.0001; CCI
contra vs CCI  Rapa ipsi p  0.0002; CCI  Rapa contra
vs CCI  Rapa ipsi p  0.0003; CCI ipsi vs CCI  Rapa
ipsi p  0.014; Fig. 1B). The effect of ionotropic glutamate
receptor blockade on spontaneous action potential firing
was determined in a subset of eGFP hilar interneurons.
Addition of kynurenic acid (30 M) significantly reduced
action potential frequency by 50% in all experimental
groups (paired t test; t(13)  5.108; p  0.0002). Synaptic
input therefore contributed significantly to action potential
frequency, and rapamycin treatment reduced, but did not
normalize action potential firing in eGFP hilar interneu-
rons ipsilateral to CCI injury. Further investigation there-
fore focused on the effect of rapamycin treatment on the
reorganization of glutamatergic synaptic input to surviving
hilar eGFP neurons.
The sEPSC frequency in eGFP hilar interneurons was
determined using whole-cell patch-clamp recordings.
Representative traces showing sEPSCs in eGFP cells
from control (i.e., sham and contralateral hemisphere),
ipsilateral to CCI injury with vehicle treatment, and ipsilat-
eral to CCI injury with rapamycin treatment groups are
shown in Figure 2A. There was an increased sEPSC fre-
quency in eGFP hilar interneurons ipsilateral to CCI
relative to sham or contralateral to CCI, as reported pre-
viously (Hunt et al., 2011; sham: 3.69 
 0.71 Hz; CCI
contra  3.65 
 0.73 Hz; CCI ipsi  10.69 
 1.36 Hz;
F(4,45)  9.478; p  0.0001
d; Tukey’s: sham vs CCI ipsi p
 0.0034; CCI contra vs CCI ipsi p  0.0003; Fig. 2B).
Rapamycin treatment significantly reduced, but did not
Figure 1. Rapamycin treatment reduces, but does not normalize,
the increased activity of hilar inhibitory interneuron 8–12 weeks
after CCI injury. A, Representative traces showing spontaneous
action potential firing from three different treatment groups:
control (i.e., sham and contralateral neurons), ipsilateral to CCI
injury  vehicle (CCI Ipsi), and ipsilateral to CCI injury  3 mg/kg
rapamycin (CCI  Rapa Ipsi). B, Mean spontaneous action
potential firing in sham, CCI Contra, CCI Ipsi, CCI  Rapa
Contra, and CCI  Rapa Ipsi groups. Error bars indicate SEM;
p  0.05 compared to sham and contralateral hemispheres;
#p  0.05 for CCI Ipsi versus CCI  Rapa Ipsi.
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normalize, the increased sEPSC frequency in ipsilateral
eGFP neurons (CCI  Rapa contra  2.66 
 0.65 Hz;
CCI  Rapa ipsi  6.60 
 1.33 Hz; Tukey’s: sham vs
CCI  Rapa ipsi p  0.0182; CCI contra vs CCI  Rapa
ipsi p  0.0356; CCI  Rapa contra vs CCI  Rapa ipsi
p  0.0127; CCI ipsi vs CCI  Rapa ipsi p  0.014; Fig.
2B). These results indicate that rapamycin treatment after
CCI reduced, but did not normalize, the increase in
sEPSC frequency in eGFP interneurons ipsilateral to
CCI injury. We therefore hypothesized that rapamycin
affected components of the reorganization of synaptic
input to surviving hilar eGFP neurons after brain injury.
To assess the influence of active CA3 pyramidal neu-
rons on glutamatergic synaptic input to surviving hilar
eGFP neurons, we microdissected the CA3 pyramidal
cell layer from the hilus and dentate gyrus. In the isolated
dentate gyrus/hilus slice, sEPSC frequency in eGFP hilar
neurons ipsilateral to CCI injury remained elevated relative to
sham and contralateral control neurons (control  3.84 

0.65 Hz, n  20; CCI ipsi  10.37 
 1.56 Hz, n  12;
one-way ANOVA; F(2,39)  8.844; p  0.0007; Tukey’s con-
trol vs CCI ipsi p  0.0005), and sEPSC frequency in mice
that received rapamycin treatment was not different from
control neurons (CCI  Rapa ipsi  7.12 
 1.62 Hz, n  10;
Tukey’s control vs CCI  Rapa ipsi p  0.13). Removing
CA3 did not significantly alter sEPSC frequency in any group
(p  0.05). Because removing CA3 did not alter the sEPSC
frequency differences between groups, and previous find-
ings indicated that action potential-independent glutamate
release in GFP hilar interneurons was elevated after CCI
(Hunt et al., 2011), we investigated the effect of rapamycin
on excitatory synaptic input arising from CA3 pyramidal cells
and DGCs.
sEPSC amplitude and whole-cell capacitance in
eGFP hilar interneurons
The amplitude of unitary sEPSCs in eGFP hilar in-
terneurons has been shown to be unaltered in CCI injured
mice compared to the contralateral hemisphere and con-
trols (Hunt et al., 2011). To assess the effect of rapamycin
on sEPSC amplitude, the amplitude of unitary sEPSCs
was compared in sham and CCI injured mice with vehicle
or rapamycin treatment. There was no difference in
amplitude of sEPSCs between experimental groups
(sham  16.65 
 2.18 pA; CCI contra  20.14 
 4.89
pA; CCI ipsi  21.49 
 2.25 pA; CCI  Rapa contra 
16.90 
 1.91 pA; CCI  Rapa ipsi  20.86 
 3.30 pA;
one-way ANOVA; F(4,45)  0.6436; p  0.7413
e; Fig.
2B). These results suggested that effects of rapamycin
on sEPSC and action potential firing frequency were
not due to postsynaptic changes in glutamate recep-
tors in eGFP hilar interneurons.
In the pilocarpine-induced SE model of TLE, an in-
crease in soma size of surviving hilar interneurons has
also been reported, and rapamycin treatment reduced the
increase in soma size associated with TLE development
(Buckmaster and Wen, 2011). As an indirect assessment
of soma size, whole-cell capacitance was measured from
Figure 2. Rapamycin treatment reduces, but does not normalize, the increase in sEPSC frequency in hilar inhibitory interneurons 8–12
weeks after CCI injury. A, Representative traces showing sEPSCs in eGFP neurons from three different treatment groups: control
(i.e., sham and contralateral neurons), ipsilateral to CCI injury  vehicle (CCI Ipsi), and ipsilateral to CCI injury  3 mg/kg rapamycin
(CCI  Rapa Ipsi). Expanded sections of the trace under the black line are indicated by arrows. B, Mean sEPSC frequency, amplitude,
and whole-cell capacitance in sham, CCI Contra, CCI Ipsi, CCI  Rapa Contra, and CCI  Rapa Ipsi groups. Error bars indicate SEM;
p  0.05 compared to sham and contralateral hemispheres; #p  0.05 for CCI Ipsi versus CCI  Rapa Ipsi; †p  0.05 compared
to sham, CCI Contra, and CCI Ipsi.
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recorded eGFP hilar interneurons to assess effects of
CCI and rapamycin treatment. An overall effect of treat-
ment was detected, but CCI injury did not increase whole-
cell capacitance of eGFP hilar interneurons in the
ipsilateral hemisphere (sham  22.31 
 1.09 pF; CCI
contra  23.36 
 0.89 pF; CCI ipsi  24.44 
 0.65 pF;
F(4,46)  8.187; p  0.0001
f; Tukey’s: sham vs CCI contra
p  0.4656; sham vs CCI ipsi p  0.1201; CCI contra vs
CCI ipsi p  0.3576; Fig. 2B). Rapamycin treatment after
CCI reduced the whole-cell capacitance of these neurons
relative to CCI alone or sham injured groups (CCI  Rapa
contra  19.22 
 0.97 pF, CCI  Rapa ipsi  16.21 

1.52 pF; Tukey’s: sham vs CCI  Rapa contra p  0.0406;
sham vs CCI  Rapa ipsi p  0.0121; CCI contra vs
CCI  Rapa contra p  0.0089; CCI ipsi vs CCI  Rapa
contra p  0.0017; CCI ipsi vs CCI  Rapa ipsi p  0.001;
CCI contra vs CCI  Rapa ipsi p  0.0023; Fig. 2B). These
data suggest that while CCI injury did not alter cell size,
rapamycin treatment reduced cell size in this hilar in-
terneuron population.
Rapamycin suppressed the injury-induced increase
in synaptic responses of eGFP interneurons after
glutamate photostimulation of DGCs
After CCI, surviving eGFP hilar interneurons ipsilateral
to injury exhibit increased excitatory synaptic input arising
from both DGCs and CA3 pyramidal neurons (Hunt et al.,
2011). mTOR inhibition reduces MFS and recurrent exci-
tation after chemoconvulsant-induced SE or CCI, and
also reduces the number of excitatory synapses per DGC
in the inner molecular layer after SE (Yamawaki et al.,
2015). In addition to these structural data, our functional
measures of spontaneous synaptic excitation and action
potential firing in eGFP hilar interneurons prompted us
to hypothesize that mTOR inhibition would inhibit synaptic
reorganization of DGC or CA3 input to hilar interneurons
after CCI. Here, recordings were performed from eGFP
hilar interneurons during glutamate photostimulation of
either the DGC layer or CA3 to assess the effect of
continuous rapamycin treatment on injury-induced syn-
aptic changes arising from these sites.
Before testing synaptic connectivity, both responses to
direct activation by glutamate uncaging (i.e., action po-
tential firing) and resting membrane potential (RMP) were
measured in the three cell types (DGCs, eGFP hilar
interneurons, and CA3 pyramidal neurons) to determine
the effect of injury and drug treatment on these intrinsic
properties (Table 2). In each cell type, neither injury nor
rapamycin treatment had a significant effect on RMP
(DGC: F(2,85)  0.1923, p  0.8254
g; eGFP interneuron:
F(2,35)  1.312, p  0.2822
h; CA3 pyramidal neuron:
F(2,26)  2.660, p  0.0889
i). Similarly, no effect of injury or
rapamycin was detected for direct responses to gluta-
mate uncaging (DGC: F(2,85)  0.3683, p  0.6928
j;
eGFP interneuron: F(2,35)  0.1197, p  0.8876
k; CA3
pyramidal neuron: F(2,26)  0.1595, p  0.8534
l). This is
consistent with previous results showing similar re-
sponses of eGFP hilar neurons and CA3 pyramidal cells
to direct glutamate photostimulation after CCI injury (Hunt
et al., 2011). Thus, RMP values and responses to direct
glutamate photostimulation (i.e., action potential number)
were comparable between groups, suggesting that
changes in the intrinsic properties of these cells did not
have a large impact on our subsequent glutamate uncag-
ing measures to assess synaptic connectivity.
Glutamate uncaging was then performed within the
DGC layer while recording synaptic responses within
eGFP hilar interneurons. Figure 3A shows representa-
tive traces of synaptic responses of eGFP hilar interneu-
rons to glutamate photostimulation of DGCs for control
(i.e., sham and vehicle/rapamycin-treated contralateral
hemispheres), ipsilateral to CCI injury with vehicle treat-
ment, and ipsilateral to CCI injury with rapamycin treat-
ment groups. A similar analysis to that of Hunt et al. (2011)
was performed to test for positive responses to glutamate
photolysis, while accounting for background sEPSCs dur-
ing each recording. A photostimulation site was consid-
ered to evoke a positive response if it resulted in a mean
eEPSC frequency 1 within a recorded eGFP hilar in-
terneuron (see Materials and Methods). Subsequently,
each recorded neuron received a score based on the
percentage of positive stimulation sites within the DGC
layer. Responses of eGFP neurons to glutamate photo-
stimulation of DGCs were tetrodotoxin (TTX)-sensitive in
5/5 (100%) of cells tested (Fig. 3C), indicating the synaptic
responses originated subsequent to action potential gen-
eration in photostimulated neurons.
The number of stimulation sites, cells, and animals from
separate treatment groups (sham-injured animals and the
contralateral and ipsilateral hemisphere of injured animals
given either vehicle or rapamycin treatment) are presented
in Table 3. No significant difference in the percentage of
Table 2. RMP and direct photoactivation measures for DGCs, eGFP hilar neurons, and CA3 pyramidal neurons
Cell type Group
Number of
cells
Number of
animals
Direct photoactivation
(number of APs) RMP (mV)
DGC Control 66 32 5.31 
 0.43 67.11 
 0.97
DGC CCI ipsi 24 7 6.04 
 0.80 66.73 
 2.18
DGC CCI  Rapa ipsi 14 7 5.54 
 0.92 65.63 
 2.03
eGFP neuron Control 20 15 3.88 
 0.57 54.72 
 1.95
eGFP neuron CCI ipsi 10 6 3.44 
 0.62 52.33 
 1.63
eGFP neuron CCI  Rapa ipsi 8 7 3.78 
 0.72 60.64 
 3.46
CA3 neuron Control 16 11 3.79 
 0.35 55.76 
 1.78
CA3 neuron CCI ipsi 7 4 4.03 
 0.76 49.53 
 2.77
CA3 neuron CCI  Rapa ipsi 6 3 3.53 
 0.61 48.39 
 4.23
No significant differences were detected within any cell type.
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Figure 3. Rapamycin treatment abrogates the injury-induced increase in synaptic input from DGCs to hilar inhibitory interneurons
8–12 weeks after CCI injury. A, Representative eEPSC responses in eGFP interneurons to glutamate photostimulation applied to
DGCs from three different treatment groups: control (i.e., sham and contralateral hemispheres), CCI Ipsi, and CCI  Rapa Ipsi. Bars
above traces indicate glutamate photostimulation period. The relative position of the recorded hilar interneuron (green) and numbered
stimulation sites in the dentate gyrus are shown on the stereotyped drawing above each set of traces; numbers for traces correspond
to stimulation site numbers in the drawing. B, Individual and mean percentage of effective stimulation sites in control, CCI Ipsi, and
CCI  Rapa Ipsi groups. C, The synaptic response of a eGFP hilar interneuron after photostimulation of DGCs (top trace) is blocked
in the presence of TTX (2 M; bottom trace), additional stimulation sweeps in gray. Error bars indicate SEM; p  0.05 compared to
control. The number of stimulation sites, cells, and animals from separate treatment groups are presented in Table 3.
Table 3. Responses of eGFP hilar inhibitory interneurons to photostimulation of DGCs and CA3 neurons
Group
Responsive DG
stimulation sites
Responsive CA3
stimulation sites
Number of
cells
Number of
animals
Net eEPSC frequency
DG stimulatio n
Net eEPSC frequency
CA3 stimulation
Sham 1/34 0/18 9 5 0.13 
 0.08 0.09 
 0.10
CCI contra 3/36 1/14 6 5 0.31 
 0.13 0.28 
 0.14
CCI ipsi 22/55 10/25 10 6 0.90 
 0.19 1.31 
 0.43
CCI  Rapa contra 1/26 1/10 5 5 0.04 
 0.10 0.02 
 0.38
CCI  Rapa ipsi 7/40 8/18 8 7 0.33 
 0.11 1.27 
 0.44
Significant differences from control indicated with an asterisk.
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effective stimulation sites to DGC photostimulation was
detected between eGFP hilar interneurons located con-
tralateral to injury (CCI  vehicle or CCI  rapamycin
treatment) or from sham-injured animals (Kruskal Wallis
stat  1.004, p  0.6053m; Table 3). Therefore, all eGFP
hilar interneuron recordings from sham injury or contralat-
eral to injury were combined into a single control group for
clarity of analysis and presentation. There was a signifi-
cant overall difference in the percentage of responsive
DGC photostimulation sites between recordings from
controls and those from the ipsilateral hemisphere of
CCI-injured animals administered either vehicle or rapa-
mycin (Kruskal-Wallis stat  16.08, p  0.0003n; Fig. 3).
Interneurons ipsilateral to CCI injury with vehicle treat-
ment exhibited a significantly greater percentage of effec-
tive stimulation sites per neuron compared to controls
(control  1 
 1.00%, CCI ipsi  37.00 
 10.09%;
Dunn’s: p  0.0002; Fig. 3). Rapamycin treatment signif-
icantly reduced the percentage of sites responsive to
DGC photostimulation, such that eGFP interneurons
from mice given CCI  rapamycin treatment were indis-
tinguishable from controls (CCI  Rapa ipsi  6.67 

4.54%; Dunn’s: vs control p  0.9999; vs CCI ipsi p 
0.0455; Fig. 3). Therefore, rapamycin treatment abrogated
the injury-induced increase in excitatory synaptic input to
eGFP interneurons arising from glutamate uncaging
within the DGC layer.
Rapamycin failed to suppress the injury-induced
increase in synaptic responses of eGFP
interneurons to photoactivation of CA3 pyramidal
cells
After CCI, CA3 pyramidal cells form new functional
connections with hilar inhibitory interneurons (Hunt et al.,
2011). In addition to photostimulation of DGCs, we also
measured responses of eGFP hilar interneurons to pho-
tostimulation of CA3 pyramidal cells. We again defined
positive synaptic response sites as sites that resulted in a
net eEPSC frequency 1 within recorded eGFP hilar
interneurons. Each recorded neuron then received a score
based on the percentage of positive stimulation sites
within the CA3 pyramidal neuron layer. Representative
traces showing responses of eGFP hilar interneurons to
glutamate photostimulation of CA3 pyramidal cells (Fig.
4A) are shown from control (i.e., sham and vehicle/
rapamycin-treated contralateral hemispheres), ipsilateral
to CCI injury with vehicle treatment, and ipsilateral to CCI
injury with rapamycin treatment groups. The number of
Figure 4. Rapamycin fails to suppress the injury-induced increase in eEPSC responses from CA3 pyramidal cells to eGFP hilar
interneurons 8–12 weeks after injury. A, Representative traces showing responses in eGFP hilar interneurons to glutamate
photostimulation applied to CA3 pyramids from three different treatment groups: control, CCI Ipsi, and CCI  Rapa Ipsi. Bars above
traces indicate glutamate photostimulation period. The relative position of the recorded hilar interneuron (green) and numbered
stimulation sites in the CA3 pyramidal cell layer are shown on the stereotyped drawing above each set of traces. B, Individual and
mean percentage of effective stimulation sites in control, CCI Ipsi, and CCI  Rapa Ipsi groups. Error bars indicate SEM; p  0.05
compared to control. The number of stimulation sites, cells, and animals from separate treatment groups are presented in Table 3.
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stimulation sites, cells, and animals from separate treat-
ment groups are presented in Table 3. Similar to the
photostimulation of DGCs, no significant difference in
response to CA3 photostimulation was detected between
sham-injured animals and those located contralateral to
injury (CCI  vehicle or CCI  rapamycin treatment;
Kruskal-Wallis stat  0.8771, p  0.6450°). Therefore,
these data were combined into a single control group. For
these controls, the average percentage of positive sites
responding to CA3 photostimulation was 4.17 
 2.93%
(Fig. 4).
Similar to responses after DGC photostimulation, there
was a significant overall increase in the percentage of
responsive CA3 photostimulation sites between record-
ings from controls and those from the ipsilateral hemi-
sphere of CCI-injured animals administered either vehicle
or rapamycin (Kruskal-Wallis stat  13.21, p  0.0014p;
Fig. 4). Interneurons from CCI-injured, vehicle-treated
mice exhibited a significantly increased percentage of
positive responding sites after CA3 pyramidal cell photo-
stimulation relative to controls (CCI ipsi  43.33 

11.97%; Dunn’s: vs control p  0.0033; Fig. 4). Unlike for
DGC photostimulation, rapamycin treatment did not sig-
nificantly suppress the CCI-induced increase in synaptic
input to eGFP interneurons arising from CA3 pyramidal
cells. Photostimulation of CA3 pyramidal cells resulted in
a significantly larger percentage of photostimulation sites
that evoked eEPSCs in eGFP hilar interneurons from the
ipsilateral hemisphere of CCI  rapamycin treated ani-
mals relative to controls (CCI  Rapa ipsi  35.42 

12.77%; Dunn’s: vs control p  0.0345; Fig. 4). There was
no significant difference in the percentage of CA3 effec-
tive stimulation sites between rapamycin- and vehicle-
treated groups after CCI injury (Dunn’s vs CCI ipsi p 
0.9999). Collectively, these results indicate that rapamy-
cin treatment reduces the excessive synaptic connections
from DGCs to eGFP hilar interneurons after focal brain
injury, but fails to suppress aberrant connections arising
from CA3 pyramidal cells.
Responses of DGCs to glutamate photostimulation
of CA3 pyramidal neurons
Sparse synaptic connections from CA3 pyramidal neu-
rons to DGCs have been described previously in naïve
rats (Scharfman, 1994a,b, 2007), and this “backprojec-
tion” may contribute to hyperexcitability of DGCs through
either monosynaptic or polysynaptic connections in mod-
els of epilepsy (Scharfman, 1994a, Scharfman et al., 2001;
Scharfman, 2007). Changes in the backprojection from
CA3 neurons to DGCs following CCI injury, and the effect
of rapamycin on this potential synaptic reorganization,
have not been previously studied. However, projections
from CA3 could contribute to the increase in excitatory
synaptic drive to DGCs observed after CCI injury (Hunt
et al., 2009, 2011; Butler et al., 2015). Glutamate photol-
ysis was used to study the CA3-to-DGC backprojection
using the same approach and analysis as performed to
test synaptic input to hilar interneurons.
The number of stimulation sites, cells, and animals from
separate treatment groups are presented in Tables 4, 5.
Synaptic responses of DGCs to photostimulation of CA3
pyramidal cells were measured in normal ACSF or when
GABAA receptors were blocked to promote synaptic dis-
inhibition. In normal ACSF, responses of DGCs to photo-
stimulation of CA3 pyramidal cells were relatively sparse;
there was no significant difference in the percentage of
effective stimulation sites in CA3 that resulted in eEPSCs
in DGCs between sham-treated mice and contralateral or
ipsilateral to CCI injury after during photostimulation of
CA3 pyramidal cells (sham  1.79 
 1.79%; CCI contra 
2.50 
 2.50%; CCI ipsi  2.78 
 2.78%: Kruskal-Wallis
stat  0.0621, p  0.9694q; Table 4; Fig. 5A). To unmask
potential polysynaptic excitatory connections, bicuculline
(30 M) was added to the ACSF and effective stimulation
sites in CA3 were again tested in sham-injured mice and
in vehicle- or rapamycin-treated, CCI-injured mice. In the
presence of bicuculline, photostimulation of CA3 again
resulted in only sparse positive responses in DGCs and
there was no significant difference between DGCs from
sham-injured mice or from the contralateral or ipsilateral
hemispheres of CCI-injured mice given vehicle or rapa-
mycin (sham  1.52 
 1.52%, CCI contra  0.0 
 0.0%,
CCI ipsi  5.83 
 3.23%, CCI  Rapa contra  0.0 

0.0%, CCI  Rapa ipsi  1.19 
 1.19%; Kruskal-Wallis
stat  6.165; p  0.1872r; Table 5; Fig. 5B). Thus, acti-
vation of CA3 pyramidal cells rarely resulted in in-
creased synaptic activation of DGCs, regardless of
injury or rapamycin treatment. The effects of mTOR
inhibition on excitatory synaptic reorganization onto
surviving hilar inhibitory interneurons after CCI injury
are summarized in Figure 6.
Discussion
Rapamycin treatment abrogates the synaptic reorgani-
zation among DGCs that occurs after SE or TBI (Buck-
master et al., 2009; Zeng et al., 2009; Buckmaster and
Lew, 2011; Guo et al., 2013; Heng et al., 2013; Butler
et al., 2015). However, the correlation of rapamycin’s
effect on this synaptic reorganization with epileptogenesis
varies across animal models. By two months after CCI
injury, spontaneous seizures and a number of cellular
correlates of posttraumatic epileptogenesis emerge in
40–50% of mice (Hunt et al., 2009, 2010; Guo et al.,
2013). Rapamycin treatment after CCI injury reduces sei-
zure prevalence and MFS, but does not block other cel-
lular changes associated with epileptogenesis (Guo et al.,
2013; Butler et al., 2015). After pilocarpine-induced SE,
rapamycin treatment does not attenuate seizures, even at
doses that block nearly all MFS (Buckmaster and Lew,
2011; Heng et al., 2013), but mTOR inhibition after kainic
acid-induced SE does reduce seizure frequency (Zeng
et al., 2009). It is important to understand the mechanistic
Table 4. Responses of DGCs to photostimulation of CA3
neurons in normal ACSF
Group
Number of effective
stimulation sites
Number of
cells
Number of
animals
Sham 1/67 14 4
CCI contra 1/46 10 6
CCI ipsi 3/57 12 5
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effects of rapamycin because it is currently in use, or is in
consideration for use, as a treatment cancer, tubular scle-
rosis and developmental malformations. The principal
findings here indicate that mTOR inhibition reduces, but
does not eliminate, the postinjury increase in excitability
of hilar inhibitory interneurons by inhibiting their down-
stream responses during activation of DGCs, without sup-
pressing their downstream responses during activation of
CA3 pyramidal cells. These results are consistent with a
rapamycin-dependent blockade of axonal sprouting of
DGCs in combination with a lack of blocking effect on
axonal sprouting of CA3 pyramidal cells (i.e., the CA3
backprojection) to these interneurons. This result implies
that there are multiple mechanistic pathways underlying
hippocampal synaptic reorganization after brain injury and
highlights the challenges of preventing reactive plasticity
associated with epileptogenesis.
This study investigated the effect of mTOR inhibition
after CCI injury on the reorganization of synaptic input to
a subset of hilar interneurons that are significantly de-
pleted in models of TBI and TLE, even when mTOR is
inhibited (Lowenstein et al., 1992; Buckmaster and Wen,
2011; Butler et al., 2016). Functionally, these interneurons
contribute to shunting of synaptic excitation through the
DGC layer, and the loss of these neurons could contribute
to increased seizure susceptibility (Buckmaster and
Dudek, 1997; Buckmaster and Wen, 2011; Hunt et al.,
2011). Synaptic reorganization originating from DGCs and
CA3 pyramidal cells onto surviving hilar interneurons may
partially compensate for the loss of these cells after brain
injury. Conversely, hyperactivity of surviving inhibitory in-
terneurons could maintain a state of imbalanced synaptic
and nonsynaptic GABAergic signaling to DGCs (Boychuk
et al., 2016), thereby degrading the overall stability of
dentate gyrus circuitry. Coordinated activity in synapti-
cally connected inhibitory neurons can also synchronize
activity in their targets, possibly due to rebound excita-
tion, and hyperexcitability of these cells may promote
epileptiform activity (Wendling et al., 2002; Bonifazi et al.,
2009; Yekhlef et al., 2015; Shiri et al., 2017). In this case,
the failure of rapamycin treatment to reduce the increased
synaptic excitation of inhibitory interneurons arising from
CA3 could increase the propensity for coordinated activity
in DGCs and maintain an underlying excitability increase
that is expressed as a reemergence of epileptogenesis
when rapamycin treatment is removed.
Ipsilateral to injury, spontaneous action potential firing
and sEPSC frequency in surviving hilar interneurons were
increased 8-12 weeks after CCI, consistent with previous
reports in models of TLE and PTE (Halabisky et al., 2010;
Hunt et al., 2011). Blocking ionotropic glutamate recep-
tors with kynurenic acid significantly reduced action po-
tential firing, implying a major role for excitatory synaptic
transmission in regulating activity of eGFP hilar in-
terneurons. We found that the injury-induced increase in
excitability of ipsilateral eGFP hilar interneurons was
reduced after rapamycin treatment, but not normalized to
control levels, with no change in the hemisphere con-
Table 5. Responses of DGCs from control groups to photostimulation of CA3 neurons in ACSF containing 30 M bicuculline
Group
Number of effective
stimulation sites
Number of
cells
Number of
animals
Net eEPSC
frequency
Sham 2/57 11 4 0.22 
 0.06
CCI contra 0/40 9 6 0.13 
 0.06
CCI ipsi 3/49 12 6 0.08 
 0.04
CCI  Rapa contra 0/49 10 7 0.05 
 0.04
CCI  Rapa ipsi 1/78 14 7 0.01 
 0.01
Figure 5. eEPSC responses in DGCs after glutamate photo-
stimulation of CA3 pyramidal cells 8–12 weeks after injury. A,
Individual and mean percentage of effective stimulation sites.
Responses in DGCs from three different treatment groups:
sham, CCI Contra, and CCI Ipsi in normal ACSF. B, Individual
and mean percentage of effective stimulation sites for DGCs in
the presence of 30 M bicuculline from three different treatment
groups: control (i.e., sham and contralateral hemispheres), CCI
Contra and Ipsi, and CCI  Rapa Contra and Ipsi. The number of
stimulation sites, cells, and animals from separate treatment
groups are presented in Tables 4, 5.
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tralateral to injury. There was no injury- or rapamycin-
induced change in sEPSC amplitudes, responses to
direct glutamate photostimulation, or RMP in any cell type
recorded, suggesting that postsynaptic changes in gluta-
mate responsiveness and intrinsic properties likely did not
account for the increase in evoked synaptic responses.
Synaptic responses to photostimulation of DGCs or CA3
cells were blocked by TTX, consistent with involvement of
intact, functional synaptic connections originating in the
activated cells.
Daily rapamycin treatment in models of PTE (Guo et al.,
2013; Butler et al., 2015) and TLE (Buckmaster et al.,
2009; Zeng et al., 2009) suppresses MFS in the inner
molecular layer of the dentate gyrus and might also be
expected to inhibit MFS in the hilus. It seems likely that
synaptic reorganization of DGCs and CA3 pyramidal cells
contributes substantially to the change in hilar interneuron
excitability. Perhaps surprisingly, removal of CA3 pyrami-
dal neurons failed to alter the pattern of EPSC frequency
changes (i.e., enhanced after CCI injury and intermediate
in rapamycin-treated mice). However, removal of CA3
would only eliminate synaptic excitation due to action
potentials, and action potential-independent vesicle re-
lease from presynaptic terminals would be preserved.
Thus, the patterns of excitatory synaptic reorganization
imply formation of new synapses. This is consistent with
previous work demonstrating that most synaptic excita-
tion in acute slices is action potential-independent (Burke,
1967; Brown et al., 1979), and that action potential-
independent, miniature EPSC frequency is elevated in
eGFP hilar neurons ipsilateral to CCI injury (Hunt et al.,
2011). Whereas rapamycin treatment normalized input
arising after activation of DGCs, consistent with effects of
mTOR inhibition on MFS and synaptic reorganization of
DGCs, there was no reduction in excitatory synaptic re-
sponses arising after stimulation of CA3 pyramidal neu-
rons, which could account for the intermediate excitability
level of hilar interneurons in rapamycin-treated mice.
These results also suggest that reactive plasticity origi-
nating from CA3 pyramidal cells after CCI injury occurs
independent of mTOR function.
The present approach with glutamate photolysis cannot
distinguish mono-synaptic versus poly-synaptic connec-
tions between either activated DGCs or activated CA3
pyramidal cells and their downstream DGC or hilar in-
terneuron targets. Postinjury connectivity of CA3 pyrami-
dal cells is not limited to the somatostatin-positive hilar
inhibitory interneurons, and backprojections to DGCs
have been proposed as a potential form of hippocampal
reorganization in epilepsy (Scharfman, 2007). In this
study, glutamate photostimulation of the CA3 pyramidal
cell layer revealed relatively sparse synaptic connectivity
with DGCs in all experimental groups, even in slices
where the hippocampal circuits were disinhibited to ex-
pose recurrent connections between pyramidal cells
(Wong and Traub, 1983). Recurrent connections between
DGCs are increased after CCI and could also contribute to
polysynaptic activation of hilar interneurons during CA3
photostimulation in the injured hemisphere. Even in the
presence of disinhibited recurrent connections between
Figure 6. Diagramatic representation of effects of rapamycin
treatment on dentate gyrus circuitry after focal brain injury. A,
Normal circuit in dentate gyrus. The projection of a DGC onto a
CA3 pyramidal cell is shown (solid black arrow). GABAergic hilar
inhibitory interneurons are also present, but are not robustly
innervated by DGCs or CA3 pyramidal cells (dashed arrows). B,
Functional synaptic input to surviving hilar interneurons arising
from activity in both DGCs and CA3 pyramidal cells (red arrows)
are increased ipsilateral to CCI injury, as are connections be-
tween DGCs (red oval; Hunt et al., 2010, 2011; Butler et al.,
2015). C, mTOR inhibition after CCI injury reduces reorganization
of functional DGC connections with surviving hilar inhibitory
interneurons, but aberrant excitatory connection arising from
CA3 pyramidal cell activity is sustained. This cartoon does not
discriminate between mono- and polysynaptic connections. Line
thickness is used as a surrogate marker for the percentage
effective stimulation sites as assessed by glutamate photolysis
here and in Hunt et al. (2010).
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principal neurons, however, CA3-to-DGC connections
were rarely detected, consistent with previous work
(Scharfman, 1994a). Hilar mossy cells might also partici-
pate in polysynaptic activation of GFP inhibitory in-
terneurons of DGCs after glutamate photolysis in the
reactive circuits studied here. Mossy cells receive con-
nections from both CA3 pyramidal neurons and DGCs,
and they innervate DGCs and hilar interneurons (Scharf-
man, 1994a,c, 1995; Larimer and Strowbridge, 2008). This
seems unlikely because the axonal morphology of mossy
cells suggests minimal participation in connections with
DGCs within the 350-m brain slices used here (Buck-
master et al., 1996; Larimer and Strowbridge, 2008).
Mossy cells make synaptic contacts with nearby hilar
neurons (Buckmaster et al., 1996) and although a large
percentage of mossy cells are killed after seizures or
moderate brain trauma (Santhakumar et al., 2000; Deng
and Xu, 2011), surviving mossy cells elaborate structurally
in a model of TLE (Zhang et al., 2015). Mossy cells can
extend small portions of their dendritic tree into both CA3
and the granule cell layer (Zhang et al., 2015), so stimu-
lation of either site could potentially activate a mossy cell
dendrite directly. That stated, rapamycin effectively re-
duced responses to photostimulation in the granule cell
layer, but not the CA3 pyramidal cell layer. If mossy cell
connections with hilar interneurons mediated the re-
sponses to photostimulation, then they should have per-
sisted after stimulation of the granule cell layer, which was
not the case. Thus, the present interpretation that down-
stream responses observed during CA3/DG photoactiva-
tion occurred by monosynaptic connections is consistent
with all of this information; however, it cannot rule out the
possibility of additional intermediate cells giving rise to
polysynaptic activation.
The relative selectivity of rapamycin’s effect on reorga-
nization of synaptic input from DGCs could be related to
the suppression of DGC neurogenesis after CCI in rapa-
mycin treated mice (Butler et al., 2015). Adult born DGCs
are hypothesized to contribute substantially to abnormal
synaptic connectivity within the dentate gyrus after an
epileptogenic insult (Parent et al., 1997), and adult born
DGCs strongly innervate inhibitory interneurons in the
absence of brain injury (Drew et al., 2016). Rapamycin’s
suppression of injury-induced neurogenesis may account
for the prevention of DGC contributions to synaptic reor-
ganization, while preserving the rapamycin-resistant in-
crease in input from CA3 pyramidal cells, especially if a
large proportion of the synaptic reorganization is due to
axons arising from adult born neurons. Thus, although
rapamycin might restrain MFS in adult DGCs, a suppres-
sive effect on adult neurogenesis could account for the
relatively selective effects on DGC, versus CA3 pyramidal
cell, input to hilar interneurons after focal brain injury.
Additional possible mechanisms could account for rap-
amycin’s effect on synaptic reorganization of input to hilar
inhibitory interneurons, including effects on metabolism
and cell growth. The pathologic weight gain that develops
after SE in mice is reversed with chronic rapamycin treat-
ment (Hester et al., 2016). Here, there was no difference in
weight gain between sham-treated and CCI-injured mice,
but chronic rapamycin treatment after CCI injury reduced
the amount of weight gained in all groups, similar to
previous reports of altered growth curves in naïve and
disease rodent models (Deblon et al., 2012; Staats et al.,
2013; Hebert et al., 2014; Hsieh et al., 2016). In addition,
somatic size of somatostatinergic hilar interneurons in-
creased after pilocarpine-induced SE, compared to con-
trol mice, and rapamycin treatment suppressed this
increase in soma size (Buckmaster and Wen, 2011). CCI
injury did not significantly alter whole-cell capacitance,
and daily rapamycin treatment reduced both contralateral
and ipsilateral whole-cell capacitance of eGFP interneu-
rons after injury, consistent with suppressive effects of
mTOR inhibition on cellular growth (Heitman et al., 1991).
Still, no functional measure from neurons contralateral to
injury was significantly different from those in sham-
injured controls, regardless of rapamycin treatment, sug-
gesting that effects on metabolism or cell growth were not
the primary mediators of rapamycin’s effect on cellular or
synaptic excitability of these neurons.
Rapamycin treatment inhibits synaptic reorganization
arising from DGCs, but not CA3 pyramids following CCI
injury, resulting in an intermediate level of synaptic exci-
tation in hilar inhibitory interneurons. A lack of effect on
reorganization of inputs arising from CA3 also suggests
different roles for mTOR in mediating reactive plasticity of
DGCs and CA3 pyramidal cells, and this is consistent with
rapamycin’s suppressive effect on adult neurogenesis af-
ter brain injury. Sustained synaptic reorganization of CA3
pyramidal cells, or other aberrant circuits, could contrib-
ute to the reemergence of epileptogenesis in models of
TLE and PTE when rapamycin treatment is ceased, even
in the absence of significant MFS (Guo et al., 2013; Heng
et al., 2013). Blocking mTOR signaling modifies, but does
not abrogate, the complex reorganization of cortical syn-
aptic circuitry after TBI, highlighting the need to better
understand the cellular changes relevant to posttraumatic
epileptogenesis and functional recovery.
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